Modern life sciences teams need faster insight, stronger control, and better ways to execute regulated work.
The 2022 Trends in Life Sciences white paper looks at the operational shifts that continue to shape pharma, biotech, and medical device organizations: decision intelligence, Computer Software Assurance, AI-enabled process automation, ecosystem collaboration, and employee experience.
The original trends were written for 2022, but the operating questions are still current. How do regulated companies turn data into decisions? How do they reduce validation drag without weakening evidence? How do they automate GxP processes responsibly? And how do they give employees tools that make controlled work easier instead of more manual?
What you will learn
- Prepare for decision intelligence: connect GxP and non-GxP data into usable models that support faster, better-controlled decisions.
- Reduce validation friction: understand why Computer Software Assurance and risk-based testing matter for modern regulated technology programs.
- Automate with control: evaluate where AI-infused GxP process automation can improve efficiency, visibility, and compliance evidence.
- Govern partner ecosystems: plan for collaboration across technology providers, consultants, regulators, and nontraditional industry participants.
- Improve the employee experience: design technology and workflows that help teams do their best work without adding avoidable administrative drag.
Why these trends still matter
Life sciences organizations have become more data-rich, platform-dependent, and partner-driven. That creates opportunity, but it also increases the need for governance. Data analytics, cloud platforms, process automation, and AI-enabled capabilities only create value when they are tied to clear ownership, reliable evidence, and inspection-ready operating models.
This white paper is useful for teams that want a concise view of the forces changing regulated operations and the practical questions leaders should ask before modernizing systems, workflows, and quality processes.
KPIs to track modernization readiness
Use these program metrics to turn the white paper themes into a practical internal review. These are measurement categories to track, not invented performance claims.
What the white paper covers
- Decision intelligence and data analytics: why companies need better data integration, scalable architecture, and access to the right operational signals.
- Computer Software Assurance: how CSA and automation can simplify validation while keeping evidence focused on risk and intended use.
- GxP process automation: where AI-infused capabilities can help regulated teams improve efficiency, insight, and process visibility.
- Collaboration for the greater good: why life sciences innovation increasingly depends on partnerships across technology, healthcare, regulatory, and operating teams.
- Employee experience: how better systems and workflows help teams execute regulated work with less friction.
Who should download it
- Quality, validation, and IT leaders modernizing regulated systems and validation practices.
- Digital transformation leaders evaluating automation, analytics, and AI-enabled workflows.
- Compliance and operations teams trying to reduce manual work while keeping inspection evidence strong.
- Executives planning life sciences technology strategy across platforms, partners, and internal teams.